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Background and aims: Coronary artery calcium (CAC) scoring is a predictor of future adverse clinical
events, and a surrogate measure of overall coronary artery plaque burden. Coronary computed tomo-
graphic angiography (CCTA) is a contrast-enhanced method that allows for visualization of plaque as well
as whether that plaque causes luminal narrowing. To date, the prognosis of individuals with CAC but
without stenosis has not been reported. We explored the prevalence of CAC>0 and its prognostic utility
for future mortality for patients without luminal narrowing by CCTA.
Methods: From 17 sites in 9 countries, we identiﬁed patients without known coronary artery disease,
who underwent CAC scoring and CCTA, and were followed for >3 years. CCTA was graded for % stenosisege and the NewYork-Presbyterian Hospital, 413 E. 69th Street, Suite 108, New York, NY, USA.
in).
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Coronary artery calcium scoring
Coronary artery diseaseaccording to a modiﬁed American Heart Association 16-segment model. We calculated hazard ratios (HR)
with 95% conﬁdence intervals (95% CI) for incident mortality and compared risk of death for patients as a
function of presence or absence of CAC and presence or absence of luminal narrowing by CCTA.
Results: Among 6656 patients who underwent CCTA and CAC scoring, 399 patients (6.0%) had no cor-
onary luminal narrowing but CAC>0. During a median follow-up of 5.1 years (IQR: 3.9e5.9 years), 456
deaths occurred. Compared to individuals without luminal narrowing or CAC, individuals without
luminal narrowing but CAC>0 were older, more likely to be male and had higher rates of diabetes, hy-
pertension, and dyslipidemia. Individuals without luminal narrowing but CAC experienced a 2-fold
increased risk of mortality, with increasing risk of mortality with higher CAC score. Following adjust-
ment, incident death persisted (HR, 1.8; 95% CI, 1.1e2.9, p ¼ 0.02) among patients without luminal
narrowing but with CAC>0 compared with patients whose CACS ¼ 0. Individuals without luminal nar-
rowing but CAC 100 had mortality risks similar to individuals with non-obstructive CAD (0 < steno-
sis<50%) by CCTA [HR 2.5 (95% CI 1.3e4.9) and 2.2 (95% CI 1.6e3.0), respectively].
Conclusions: Patients without luminal narrowing but with CAC experience greater risk of 5-year mor-
tality. Patients with CAC score 100 and no coronary luminal narrowing experience death rates similar to
those with non-obstructive CAD.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Coronary artery calcium (CAC) scoring is a useful non-contrast
enhanced imaging method for visualization of calciﬁed coronary
plaque, and represents a surrogate marker of overall plaque burden
independent of stenosis severity. Prior population-based studies
have established the relationship between CAC and worsened
cardiovascular prognosis [1e3]. Coronary computed tomographic
angiography (CCTA) is a non-invasive imaging modality with high
diagnostic accuracy for diagnosis of coronary luminal stenosis and
atherosclerotic plaque [4,5], the latter of which may exist in the
absence of coronary luminal diameter reduction due to positive
arterial remodeling. To date, the prognostic implications of CAC in
the absence of coronary luminal narrowing remains unknown. The
present prospective multicenter study was set out to examine the
prevalence and prognosis of CAC, in the absence of coronary
luminal narrowing, in patients without clinical manifestations of
coronary artery disease (CAD).
2. Materials and methods
The initial study design and rationale of the CONFIRM (COronary
CT Angiography EvaluatioN For Clinical Outcomes: An InteRna-
tional Multicenter) registry has been described previously [6]. In
brief, the CONFIRM registry was designed to evaluate the ability of
CCTA ﬁndings to predict mortality and major adverse cardiac
events in patients with chronic CAD. For the current study, we
utilized data from the CONFIRM long-term follow-up registry,
which only included patients who had a follow-up duration of
more than 3 years. Overall, 17181 patients who underwent CCTA at
17 centers in 9 countries (Austria, Canada, Germany, Israel, Italy,
Portugal, South Korea, Switzerland, and United States) were
enrolled between February 2003 and May 2011 for long-term
follow-up. Inclusion criteria were age 18 years or older, an evalu-
ation by CCTA scanner with 64-detector rows or greater, and the
presence of interpretable CCTA. For the current study, we excluded
patients according to the following exclusion criteria: the absence
of CAC data (n ¼ 9626) or CCTA stenosis information (n ¼ 214), the
absence of age or gender information (n ¼ 12), or prior history of
CAD (n ¼ 639). The analytic sample comprised 6656 patients. Each
of the study centers' institutional review boards approved the study
protocol, and all study participants provided written informed
consent.
CCTA and CAC data were acquired using multi-detector row CT
scanners consisting of 64-rows or greater. Expert imagers(cardiologists and radiologists) analyzed all CCTA images and
measured CAC. Data acquisition, image post-processing, and data
interpretation were performed according to the guidelines of the
Society of Cardiovascular Computed Tomography (SCCT) [7e9]. CAC
were measured using the scoring system (in units) developed by
Agatston et al. [10]. For CCTA, we deﬁned the coronary athero-
sclerosis as any tissue structures larger than 1 mm2, which were
either within the lumen of the coronary artery or adjacent to the
coronary artery lumen that could be distinguished from adjacent
epicardial fat, pericardial tissue, or the artery lumen itself. We
examined all identiﬁed lesions by maximum-intensity-projection
and multi-planar reconstruction techniques, along multiple longi-
tudinal axes, and in the transverse plane. For the current analyses,
we used a modiﬁed American Heart Association (AHA) 16-segment
coronary artery tree model [11]: left main; proximal, mid and distal
left anterior descending (LAD) artery; ﬁrst and second diagonal
branches of the LAD; proximal and distal left circumﬂex artery; ﬁrst
and second obtuse marginal branches of the left circumﬂex artery;
proximal, mid and distal right coronary artery; posterior descend-
ing artery; and postero-lateral branches (left or right). Coronary
artery luminal narrowingwas deﬁned as the presence of any plaque
resulting in a % diameter reduction >0: obstructive stenosis was
deﬁned as coronary artery plaques imparting luminal diameter
stenosis 50%, while non-obstructive stenosis was deﬁned as cor-
onary artery segments displaying plaque with a luminal diameter
stenosis 1e49%. The total mean dose length product for CCTA and
coronary artery calcium scans was estimated to be
883 ± 379mGy cm, corresponding to an estimated radiation dose
of 12 ± 5 mSv [12].
2.1. Patient follow-up
The primary outcome of the current study was all-cause mor-
tality. Trained personnel from each participating institution adju-
dicated the study endpoint via direct interview with physicians,
next-of-kin and/or witnesses, by review of hospital records, or by
querying of national medical databases. All patients were ques-
tioned using a scripted interview, and all procedures were
conﬁrmed by review of the patients' medical record.
2.2. Statistical methods
Continuous variables are expressed as means ± standard devi-
ation (SD), and categorical variables are presented as numbers with
proportions. Differences between continuous variables among
Fig. 1. Representative images of arteries without coronary luminal stenosis but coro-
nary artery calcium.
Calciﬁed plaque in (A) proximal left anterior descending (LAD) and (B) left main cor-
onary artery without luminal narrowing was observed in multiplanar reconstruction
images.
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using one-way ANOVA with Bonferroni correction for post-hoc
analyses. Differences between categorical variables were analyzed
by Х2 test or Fisher's exact test, as appropriate. We fashioned a
KaplaneMeier curve to obtain the cumulative event rates as a
function of time, with each survival curve compared using the log-
rank test. Univariable and multivariable Cox regression models,
with adjustment of Framingham risk scores reporting hazard ratios
(HR) with 95% conﬁdence limits (95% CI), were calculated to
identify associations between CCTA and CAC variables with the
study outcome. We evaluated the risk of death speciﬁcally
comparing patients without luminal narrowing by CCTA but with
CAC score >0 with subgroups of patients classiﬁed on the back-
ground of CAC and non-obstructive or obstructive CAD, as detected
by CCTA.
3. Results
Among 6656 patients who underwent both CCTA and CAC
scanning, 2166 (32.5%) individuals were identiﬁed as having no
luminal stenosis by CCTA and CACS ¼ 0 (Table 1). Conversely, 399
(6.0%) patients had no luminal narrowing by CCTA but CAC score >0
(Fig. 1). Among these, 296 (4.4%) and 103 (1.6%) patients without
stenosis by CCTA were identiﬁed as having a CAC score between 1
and 99 and 100, respectively. Patients without luminal narrowing
by CCTA but CAC score>0 tended to be older, predominantly male,
more hypertensive, diabetic, and dyslipidemic than those without
luminal narrowing by CCTA and CACS ¼ 0 (all p < 0.001) (Table 2).
Compared to patients with non-obstructive or obstructive stenosis,
patients without luminal narrowing by CCTA but CAC>0 were
younger (p < 0.001), with a lower prevalence of hypertension
(p < 0.001), dyslipidemia (p ¼ 0.017), and active smoking
(p ¼ 0.005).
During a median follow-up of 5.1 years (interquartile range:
3.9e5.9 years), 456 deaths occurred. Patients without luminal
narrowing by CCTA but with CAC experienced a signiﬁcantly higher
rate of death than patients without luminal narrowing by CCTA and
no CAC (p ¼ 0.005) (Fig. 2). This increased risk was similar to that
imparted by the presence of non-obstructive coronary stenosis by
CCTA (p ¼ 0.229), but lower than that conferred by the presence of
obstructive coronary stenosis by CCTA (p < 0.001).
Among the 2166 patients without stenosis and no CAC, 61
deaths occurred with a 5-year cumulative mortality of 2.9% (95% CI,
2.2%e3.8%) (Table 3). In contrast, 23 deaths occurred among the
399 patients without luminal narrowing but with CAC >0, with a 5-
year cumulative mortality of 6.2% (95% CI, 4.0%e9.6%). The mor-
tality incidence for the 103 patients without stenosis but CAC 100
was 7.1% (95% CI, 3.2%e15.0%), a rate similar to patients with non-
obstructive stenosis [8.1% (95% CI, 7.0%e9.4%)]. Among all groups,
patients with obstructive coronary stenosis experienced the high-
est rates of death (11.6%; 95% CI, 10.0%e13.4%).Table 1
Distribution of patients according to coronary CT angiography ﬁndings and coronary
artery calcium score.
CCTA CAC score No of patients (%)
No stenosis 0 2166 (32.5%)
>0 399 (6.0%)
0% < stenosis<50% 2404 (36.1%)
0 430 (6.5%)
>0 1974 (29.6%)
50% stenosis 1687 (25.4%)
0 172 (2.6%)
>0 1515 (22.8%)
CCTA, coronary CT angiography; CAC, coronary artery calcium.In Table 4, univariable Cox regression analyses revealed the
presence of CAC in patients without coronary luminal narrowing to
be a signiﬁcant predictor of death (HR, 2.0; 95% CI 1.3e3.3,
p ¼ 0.003) compared with those without coronary luminal nar-
rowing and no CAC. In those individuals with no coronary luminal
narrowing but CAC>0, risk of all-cause death grew as CAC score
increased. After adjustment for the FRS, a 2-fold increased risk of
death was observed for individuals with CAC but without coronary
luminal narrowing (HR, 1.8; 95% CI, 1.1e2.9, p ¼ 0.020) compared
with patients without coronary luminal narrowing and no CAC. In
subgroup analysis, patients with a CAC score 100 had a signiﬁ-
cantly increased risk of death (HR, 2.5; 95% CI, 1.3e4.9) compared
with those without coronary luminal narrowing and no CAC and
similar risk of death compared with non-obstructive luminal nar-
rowing patients (HR, 2.2; 95% CI, 1.6e3.0).4. Discussion
In this global multicenter study, we evaluated the prevalence of
CAC and its associated prognosis in patients without luminal nar-
rowing by CCTA. Given the long-term follow-up, the multinational
enrollment and the large population studied, these ﬁndings should
be considered to be highly generalizable. We identiﬁed a non-
negligible frequency of individuals without stenosis but with
evident coronary calcium, with 1 of 17 individuals exhibiting this
pattern. Individuals with CAC but without luminal narrowing, as
compared to individuals without CAC and stenosis, tended to be
older, male and with a higher prevalence of traditional coronary
heart disease risk factors, including hypertension, dyslipidemia and
diabetes. Indeed, the prevalence of diabetes was 2-fold higher for
individuals without stenosis and CAC when compared to in-
dividuals without stenosis or CAC.
Importantly, we observed a worsened prognosis of individuals
without luminal narrowing but with CAC. Compared to individuals
without luminal narrowing or CAC, there was a more than 2-fold
increased risk of mortality during the 5 years of follow-up. This
increased risk exhibited a dose-response curve, with risk of 5-year
mortality exceeding 7% for individuals without luminal narrowing
but CAC score100, a rate similar to the 8.1%mortality observed for
individuals with non-obstructive stenosis by CCTA. The absolute
event rates mirrored the relative risk wherein the hazards for death
was 2.5 and 2.2 for individuals without luminal narrowing but CAC
score 100 and individuals with non-obstructive stenosis by CCTA,
Table 2
Baseline characteristics of study patients.
Variables Total
(N ¼ 6656)
CCTA: No stenosis, CAC score ¼ 0
(N ¼ 2166)
CCTA: No stenosis, CAC score>0
(N ¼ 399)
CCTA: Any stenosis
(N ¼ 4091)
p-value for
ANOVA
Age (years) 59 ± 13 52 ± 12 60 ± 12* 63 ± 11*y <0.001
Gender (male) 3947 (59%) 1007 (47%) 250 (63%)* 2690 (66%)* <0.001
Hypertension 3476 (53%) 858 (40%) 199 (50%)* 2419 (59%)*y <0.001
Diabetes 973 (15%) 171 (8%) 62 (16%)* 740 (18%)* <0.001
Current smoking 1216 (18%) 341 (16%) 58 (15%) 817 (20%)*y <0.001
BMI (kg/m2) 28 ± 5 27 ± 5 28 ± 6 28 ± 5* <0.001
Dyslipidemia 3646 (55%) 893 (41%) 223 (57%)* 2530 (62%)*y <0.001
Total cholesterol, mg/
dL
191 ± 45 197 ± 42 181 ± 44* 187 ± 47* <0.001
LDL cholesterol, mg/
dL
113 ± 37 117 ± 35 107 ± 37* 111 ± 38* <0.001
HDL cholesterol, mg/
dL
54 ± 18 57 ± 19 51 ± 17* 52 ± 17* <0.001
Continuous values are mean ± standard deviation and categorical values are number and percentage (%).
*p < 0.001 compared with patients without luminal narrowing by CCTA and with zero CACS.
yp < 0.05 compared with patients without luminal narrowing by CCTA but with CAC score above zero.
BMI, bodymass index; CACS, coronary artery calcium score; CCTA, cardiac computed tomographic angiography; HDL, high density lipoprotein; LDL, low density lipoprotein; N,
number.
Fig. 2. Kaplan-Meier survival curve for all-cause mortality according to coronary artery calcium score and coronary computed tomographic angiography ﬁndings.
Table 3
Prevalence and rates of mortality as a function of CAC score and CCTA ﬁndings.
CCTA CAC score Number of events/Total population 5-year KM estimates of event, % (95% CI)
No stenosis 0 61/2166 2.9 (2.2e3.8)
>0 23/399 6.2 (4.0e9.6)
1e99 13/296 5.9 (3.5e9.9)
100 10/103 7.1 (3.2e15.0)
0% < stenosis <50% 156/1974 8.1 (7.0e9.4)
50% stenosis 161/1515 11.6 (10.0e13.4)
CCTA, coronary CT angiography; CAC, coronary artery calcium; No, number; KM, Kaplan-Meyer; CI, conﬁdence interval.
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ease on CCTA, deﬁned by stenosis of 1e49%, has previously been
shown to be associated with increased mortality rates [13]. The
results of this study suggest that the ﬁnding of CAC but no luminal
narrowing on CCTA is another form of non-obstructive CAD and
should not be considered normal. Thus, aggressive risk factor
control should perhaps be considered among this patient
population.The reasons for classiﬁcation of individuals with CAC but
without luminal narrowing warrant consideration. Expansive
remodeling of coronary arteries to accommodate increasing plaque
burden is a well-recognized compensatory mechanism to preserve
coronary luminal integrity. Given the ability of CCTA to evaluate
both the arterial lumen and wall, imagers evaluating CCTA can
identify atherosclerotic plaques that do versus do not cause luminal
narrowing. In the present study cohort, the overall plaque burden
Table 4
Univariate and multivariate Cox regression models for all-cause mortality according
to CAC and CCTA ﬁndings.
CCTA CAC score Unadjusted Adjusted for FRS
HR (95% CI) p-value HR (95% CI) p-value
No stenosis 0 Reference NA Reference NA
>0 2.0 (1.3e3.3) 0.003 1.8 (1.1e2.9) 0.020
1e99 1.6 (0.9e2.9) 0.140 1.4 (0.8e2.6) 0.230
100 3.3 (1.7e6.5) <0.001 2.5 (1.3e4.9) 0.008
0% < stenosis <50% 2.7 (2.0e3.6) <0.001 2.2 (1.6e3.0) <0.001
50% stenosis 4.1 (3.0e5.5) <0.001 2.9 (2.2e4.0) <0.001
CCTA, coronary CT angiography; CAC, coronary artery calcium; CI, conﬁdence in-
terval; FRS, Framingham risk score; HR, hazard ratio; NA, not applicable.
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edly low. Despite this, however, the prognosis associated with its
presence exhibited impactful adverse consequences. Prior studies
evaluating positive arterial remodeling by CCTA have shown its
collinearity with other atherosclerotic plaque features, such as
plaque burden and necrotic intra-plaque core [14]. Indeed, plaques
undergoing positive arterial remodeling exhibit higher rates of
ischemia when compared to invasive fractional ﬂow reserve, and
are associated with higher rates of downstream acute coronary
syndromes compared to those that do not [15].
Our study ﬁndings should serve to raise awareness with respect
to current CCTA reporting. Further to prior investigations that have
reported the importance of atherosclerotic plaque features to more
precisely deﬁne prognosis, the present study data indicates the
importance of these characteristics, even when coronary luminal
compromise is not present. Allowing for the importance of these
ﬁndings, the most recent guidelines, which were published in 2009
and 2014, requested that the presence of coronary atherosclerosis
should be reported, and speciﬁcally stated that intramural plaque
without luminal stenosis should be reported as minimal (grade 1)
in the qualitative scales and quantitative scales [9,16]. However,
given that the patient enrollment and CCTA interpretation had been
done between February 2003 and May 2011 in CONFIRM registry,
our study ﬁndings showed that non-negligible proportion of those
patients were classiﬁed and reported as normal (grade 0). Another
potential method for reporting this may be to couple CCTA and CAC
reporting, but this method may not fully embody the totality of
adverse plaque ﬁndings, and future studies should be performed to
identify the most parsimonious methods to comprehensively
deﬁne risk and promote salutary therapeutic interventions.
The current study is not without limitations. CCTAs were
interpreted by experts at each site rather than a dedicated core
laboratory. As such, we attempted to minimize potential biases by
applying standardized data deﬁnitions that included only sites
where interpretation of CCTAs were led by cardiologist/radiologists
with adequate proﬁciency. Patients with both CCTA and CACS re-
sults were only included in the current analysis, hence the potential
for selection bias may have inﬂuenced our study ﬁndings. Further,
CCTA and CAC both possess intrinsic technological limitations that
may introduce imaging artifacts that may have affected our study
ﬁndings. Future generation CT scanners may address these artifacts,
but we employed CT scanners of 64 detector rows, which is
considered the clinical standard for performance of CCTA and CAC.
Further, we observed important prognostic ﬁndings with the use of
this standard-of-care technology. Finally, our study did not evaluate
the ﬁndings of non-calciﬁed plaque in patients with no luminal
narrowing.We also did not systematically evaluate other important
plaque features, such as plaque volume or low attenuation plaque
as a surrogate marker of necrotic lipid-laden intra-plaque cores.
Given the high number of CTs evaluated and the lack of diagnosticsoftware at the time of initiation of this study, we were unable to
perform this important task, which should be addressed in future
studies.
In this prospective multicenter international study, the presence
of CAC in the absence of coronary luminal narrowing is associated
with increased 5-year risk of mortality. Individuals with CAC score
100 and no coronary luminal narrowing experience death rates
similar to those with non-obstructive CAD.
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